Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
about
Response of Mouse Breast Cancer Cells to Anastrozole, Tamoxifen, and the Combination.Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials.Toremifene-atamestane; alone or in combination: predictions from the preclinical intratumoral aromatase modelRandomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer.HPMA copolymer-aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines.Antitumorigenic effects of tamoxifen, raloxifene and the combination on the development of breast tumors induced by mouse mammary carcinoma cells in balb/c-J female mice.
P2860
Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
@ast
Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
@en
Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
@nl
type
label
Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
@ast
Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
@en
Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
@nl
prefLabel
Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
@ast
Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
@en
Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
@nl
P1433
P1476
Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
@en
P2093
Kathrin Strasser
Paul E Goss
P304
P356
10.2165/00003495-200262060-00007
P577
2002-01-01T00:00:00Z
P6179
1001402882